Holdings (Monthly)
Guide ↗
Putnam Global Health Care Fund
| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. | 532457108 | Feb 2026 | 171,340 | $180.2M | 11.34% | EC |
| 2 | Johnson & Johnson | 478160104 | Feb 2026 | 569,943 | $141.6M | 8.91% | EC |
| 3 | AbbVie, Inc. | 00287Y109 | Feb 2026 | 406,900 | $94.4M | 5.94% | EC |
| 4 | Novartis AG | N/A | Feb 2026 | 522,868 | $87.9M | 5.53% | EC |
| 5 | Merck & Co., Inc. | 58933Y105 | Feb 2026 | 684,671 | $84.8M | 5.33% | EC |
| 6 | AstraZeneca plc | N/A | Feb 2026 | 381,146 | $80.2M | 5.04% | EC |
| 7 | UnitedHealth Group, Inc. | 91324P102 | Feb 2026 | 266,960 | $78.3M | 4.92% | EC |
| 8 | Intuitive Surgical, Inc. | 46120E602 | Feb 2026 | 123,020 | $61.9M | 3.90% | EC |
| 9 | Thermo Fisher Scientific, Inc. | 883556102 | Feb 2026 | 112,920 | $58.8M | 3.70% | EC |
| 10 | Roche Holding AG | N/A | Feb 2026 | 97,154 | $46.2M | 2.91% | EC |
| 11 | Boston Scientific Corp. | 101137107 | Feb 2026 | 587,248 | $45.1M | 2.84% | EC |
| 12 | Gilead Sciences, Inc. | 375558103 | Feb 2026 | 286,000 | $42.6M | 2.68% | EC |
| 13 | McKesson Corp. | 58155Q103 | Feb 2026 | 42,240 | $41.7M | 2.62% | EC |
| 14 | Medtronic plc | N/A | Feb 2026 | 402,600 | $39.3M | 2.47% | EC |
| 15 | Sanofi SA | N/A | Feb 2026 | 379,940 | $37.2M | 2.34% | EC |
| 16 | Vertex Pharmaceuticals, Inc. | 92532F100 | Feb 2026 | 73,860 | $36.7M | 2.31% | EC |
| 17 | Cardinal Health, Inc. | 14149Y108 | Feb 2026 | 157,400 | $36.1M | 2.27% | EC |
| 18 | Bristol-Myers Squibb Co. | 110122108 | Feb 2026 | 530,200 | $33.1M | 2.08% | EC |
| 19 | CVS Health Corp. | 126650100 | Feb 2026 | 366,300 | $29.3M | 1.84% | EC |
| 20 | Ascendis Pharma A/S | 04351P101 | Feb 2026 | 113,788 | $26.6M | 1.67% | EC |
| 21 | Edwards Lifesciences Corp. | 28176E108 | Feb 2026 | 298,500 | $25.8M | 1.62% | EC |
| 22 | HCA Healthcare, Inc. | 40412C101 | Feb 2026 | 45,780 | $24.2M | 1.53% | EC |
| 23 | Novo Nordisk A/S | N/A | Feb 2026 | 610,832 | $23.1M | 1.45% | EC |
| 24 | Putnam Short Term Investment Fund | 74676P664 | Feb 2026 | 21,062,165 | $21.1M | 1.32% | — |
| 25 | Alnylam Pharmaceuticals, Inc. | 02043Q107 | Feb 2026 | 62,800 | $20.9M | 1.32% | EC |
| 26 | Chugai Pharmaceutical Co. Ltd. | N/A | Feb 2026 | 296,300 | $20.0M | 1.26% | EC |
| 27 | Hoya Corp. | N/A | Feb 2026 | 109,700 | $19.8M | 1.25% | EC |
| 28 | Regeneron Pharmaceuticals, Inc. | 75886F107 | Feb 2026 | 25,018 | $19.6M | 1.23% | EC |
| 29 | UCB SA | N/A | Feb 2026 | 54,918 | $16.5M | 1.04% | EC |
| 30 | Argenx SE | N/A | Feb 2026 | 20,864 | $16.1M | 1.02% | EC |
| 31 | Abbott Laboratories | 002824100 | Feb 2026 | 135,900 | $15.8M | 0.99% | EC |
| 32 | Becton Dickinson & Co. | 075887109 | Feb 2026 | 88,700 | $15.7M | 0.98% | EC |
| 33 | GSK plc | N/A | Feb 2026 | 509,032 | $15.1M | 0.95% | EC |
| 34 | Vaxcyte, Inc. | 92243G108 | Feb 2026 | 228,000 | $14.1M | 0.89% | EC |
| 35 | Insmed, Inc. | 457669307 | Feb 2026 | 89,900 | $13.4M | 0.84% | EC |
| 36 | Rhythm Pharmaceuticals, Inc. | 76243J105 | Feb 2026 | 107,800 | $10.0M | 0.63% | EC |
| 37 | Newamsterdam Pharma Co. NV | N/A | Feb 2026 | 113,900 | $4.0M | 0.25% | EC |
| 38 | Precigen, Inc. | 74017N105 | Feb 2026 | 910,700 | $3.5M | 0.22% | EC |
| 39 | Putnam Cash Collateral Pool LLC | 99311N9A5 | Feb 2026 | 2,403,534 | $2.4M | 0.15% | STIV |
| 40 | United States of America | 912797TN7 | Feb 2026 | 1,900,000 | $1.9M | 0.12% | STIV |
| 41 | N/A | N/A | Feb 2026 | 43,285,080 | $1.7M | 0.10% | DE |
| 42 | N/A | N/A | Feb 2026 | 1 | $1.1M | 0.07% | DFE |
| 43 | N/A | N/A | Feb 2026 | 1 | $991K | 0.06% | DFE |
| 44 | N/A | N/A | Feb 2026 | 16,954,400 | $528K | 0.03% | DE |
| 45 | United States of America | 912797SM0 | Feb 2026 | 500,000 | $497K | 0.03% | STIV |
| 46 | N/A | N/A | Feb 2026 | 1 | $303K | 0.02% | DFE |
| 47 | N/A | N/A | Feb 2026 | 1 | $290K | 0.02% | DFE |
| 48 | N/A | N/A | Feb 2026 | 1 | $257K | 0.02% | DFE |
| 49 | N/A | N/A | Feb 2026 | 1 | $180K | 0.01% | DFE |
| 50 | N/A | N/A | Feb 2026 | 1 | $155K | 0.01% | DFE |
| 51 | N/A | N/A | Feb 2026 | 1 | $131K | 0.01% | DFE |
| 52 | N/A | N/A | Feb 2026 | 1 | $118K | 0.01% | DFE |
| 53 | N/A | N/A | Feb 2026 | 1 | $100K | 0.01% | DFE |
| 54 | N/A | N/A | Feb 2026 | 1 | $91K | 0.01% | DFE |
| 55 | N/A | N/A | Feb 2026 | 1 | $87K | 0.01% | DFE |
| 56 | N/A | N/A | Feb 2026 | 1 | $83K | 0.01% | DFE |
| 57 | N/A | N/A | Feb 2026 | 1 | $72K | 0.00% | DFE |
| 58 | N/A | N/A | Feb 2026 | 1 | $57K | 0.00% | DFE |
| 59 | N/A | N/A | Feb 2026 | 1 | $56K | 0.00% | DFE |
| 60 | N/A | N/A | Feb 2026 | 1 | $50K | 0.00% | DFE |
| 61 | N/A | N/A | Feb 2026 | 1 | $49K | 0.00% | DFE |
| 62 | N/A | N/A | Feb 2026 | 1 | $47K | 0.00% | DFE |
| 63 | N/A | N/A | Feb 2026 | 1 | $42K | 0.00% | DFE |
| 64 | N/A | N/A | Feb 2026 | 1 | $40K | 0.00% | DFE |
| 65 | N/A | N/A | Feb 2026 | 1 | $36K | 0.00% | DFE |
| 66 | N/A | N/A | Feb 2026 | 1 | $26K | 0.00% | DFE |
| 67 | N/A | N/A | Feb 2026 | 1 | $24K | 0.00% | DFE |
| 68 | N/A | N/A | Feb 2026 | 1 | $24K | 0.00% | DFE |
| 69 | N/A | N/A | Feb 2026 | 1 | $23K | 0.00% | DFE |
| 70 | N/A | N/A | Feb 2026 | 1 | $22K | 0.00% | DFE |
| 71 | N/A | N/A | Feb 2026 | 1 | $21K | 0.00% | DFE |
| 72 | N/A | N/A | Feb 2026 | 1 | $19K | 0.00% | DFE |
| 73 | N/A | N/A | Feb 2026 | 1 | $16K | 0.00% | DFE |
| 74 | N/A | N/A | Feb 2026 | 1 | $16K | 0.00% | DFE |
| 75 | N/A | N/A | Feb 2026 | 1 | $13K | 0.00% | DFE |
| 76 | N/A | N/A | Feb 2026 | 1 | $12K | 0.00% | DFE |
| 77 | N/A | N/A | Feb 2026 | 1 | $11K | 0.00% | DFE |
| 78 | N/A | N/A | Feb 2026 | 1 | $9K | 0.00% | DFE |
| 79 | N/A | N/A | Feb 2026 | 1 | $8K | 0.00% | DFE |
| 80 | N/A | N/A | Feb 2026 | 1 | $6K | 0.00% | DFE |
| 81 | N/A | N/A | Feb 2026 | 1 | $5K | 0.00% | DFE |
| 82 | N/A | N/A | Feb 2026 | 1 | $4K | 0.00% | DFE |
| 83 | N/A | N/A | Feb 2026 | 1 | $3K | 0.00% | DFE |
| 84 | N/A | N/A | Feb 2026 | 1 | $2K | 0.00% | DFE |
| 85 | N/A | N/A | Feb 2026 | 1 | $2K | 0.00% | DFE |
| 86 | N/A | N/A | Feb 2026 | 1 | $196 | 0.00% | DFE |
| 87 | N/A | N/A | Feb 2026 | 1 | $130 | 0.00% | DFE |
| 88 | N/A | N/A | Feb 2026 | 1 | $32 | 0.00% | DFE |
| 89 | EURO | N/A | Feb 2026 | 1 | $1 | 0.00% | STIV |
| 90 | Danish Krone | N/A | Feb 2026 | 0 | $0 | 0.00% | STIV |
| 91 | N/A | N/A | Feb 2026 | 1 | $-403 | -0.00% | DFE |
| 92 | N/A | N/A | Feb 2026 | 1 | $-603 | -0.00% | DFE |
| 93 | N/A | N/A | Feb 2026 | 1 | $-749 | -0.00% | DFE |
| 94 | N/A | N/A | Feb 2026 | 1 | $-899 | -0.00% | DFE |
| 95 | N/A | N/A | Feb 2026 | 1 | $-3302 | -0.00% | DFE |
| 96 | N/A | N/A | Feb 2026 | 1 | $-4373 | -0.00% | DFE |
| 97 | N/A | N/A | Feb 2026 | 1 | $-5045 | -0.00% | DFE |
| 98 | N/A | N/A | Feb 2026 | 1 | $-15910 | -0.00% | DFE |
| 99 | N/A | N/A | Feb 2026 | 1 | $-17006 | -0.00% | DFE |
| 100 | N/A | N/A | Feb 2026 | 1 | $-18289 | -0.00% | DFE |
| 101 | N/A | N/A | Feb 2026 | 1 | $-20714 | -0.00% | DFE |
| 102 | N/A | N/A | Feb 2026 | 1 | $-27605 | -0.00% | DFE |
| 103 | N/A | N/A | Feb 2026 | 1 | $-28438 | -0.00% | DFE |
| 104 | N/A | N/A | Feb 2026 | 1 | $-30594 | -0.00% | DFE |
| 105 | N/A | N/A | Feb 2026 | 1 | $-32489 | -0.00% | DFE |
| 106 | N/A | N/A | Feb 2026 | 1 | $-34047 | -0.00% | DFE |
| 107 | N/A | N/A | Feb 2026 | 1 | $-39975 | -0.00% | DFE |
| 108 | N/A | N/A | Feb 2026 | 1 | $-59625 | -0.00% | DFE |
| 109 | N/A | N/A | Feb 2026 | 1 | $-66847 | -0.00% | DFE |
| 110 | N/A | N/A | Feb 2026 | 1 | $-68001 | -0.00% | DFE |
| 111 | N/A | N/A | Feb 2026 | 1 | $-126130 | -0.01% | DFE |
| 112 | N/A | N/A | Feb 2026 | 1 | $-136419 | -0.01% | DFE |
| 113 | N/A | N/A | Feb 2026 | 1 | $-146404 | -0.01% | DFE |
| 114 | N/A | N/A | Feb 2026 | 1 | $-147815 | -0.01% | DFE |
| 115 | N/A | N/A | Feb 2026 | 1 | $-210904 | -0.01% | DFE |
| 116 | N/A | N/A | Feb 2026 | 1 | $-332375 | -0.02% | DFE |
| 117 | N/A | N/A | Feb 2026 | 1 | $-395063 | -0.02% | DFE |
| 118 | N/A | N/A | Feb 2026 | 1 | $-613190 | -0.04% | DFE |
| 119 | N/A | N/A | Feb 2026 | -46,108,020 | $-850134 | -0.05% | DE |